Expression and activation of proteases in co-cultures

Experimental and Toxicologic Pathology

Volumn 63, Issue 1-2, 2011, Pages 79-87

  Paduch, Roman ^a   Kandefer Szerszeń, Martyna ^a  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

Co culture; MMP 2; MMP 9; Monensin; UPA uPAR system

Indexed keywords

CHROMOGENIC SUBSTRATE; GELATINASE A; GELATINASE B; MONENSIN; PROTEINASE; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL INTERACTION; CELL LYSATE; CELL TYPE; COCULTURE; COLON CARCINOMA; COLON MUCOSA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MONOCULTURE; MYOFIBROBLAST; PROTEIN EXPRESSION; SUPERNATANT; TUMOR CELL; TUMOR GROWTH; TUMOR SPHEROID; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; ZYMOGRAPHY;

CELL COMMUNICATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MONENSIN; MYOFIBROBLASTS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PEPTIDE HYDROLASES; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SPHEROIDS, CELLULAR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 78650174730     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2009.09.011     Document Type: Article

References (27)

1. Baker E.A., Leaper D.J. Measuring gelatinase activity in colorectal cancer. Eur J Surg Oncol 2002, 28:24-29.
2. Berger D.H. Plasmin/plasminogen system in colorectal cancer. World J Surg 2002, 26:767-771.
3. Buø L., Meling G.I., Karlsrud T.S., Johansen H.T., Aasen A.O. Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness. Hum Pathol 1995, 26:1133-1138.
4. Cavallaro U., Soria M.R. Targeting plant toxins to the urokinase and α2-macroglobulin receptor. Semin Cancer Biol 1995, 6:269-278.
5. Collins H.M., Morris T.M., Watson S.A. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase. Br J Cancer 2001, 84:1664-1670.
6. Fernebro E., Madsen R.R., Fernö M., Brünner N., Bendahl P.-O., Christensen I.J., et al. Prognostic importance of the soluble plasminogen activator receptor; suPAR, in plasma from rectal cancer patients. Eur J Cancer 2001, 37:486-491.
7. Gimeno-García A.Z., Santana-Rodríguez A., Jiménez A., Parra-Blanco A., Nicolás-Pérez D., Paz-Cabrera C., et al. Up-regulation of gelatinases in the colorectal adenoma-carcinoma sequence. Eur J Cancer 2006, 42:3246-3252.
8. Herszényi L., Plebani M., Carraro P., De Paoli M., Roveroni G., Cardin R., et al. Proteases in gastrointestinal neoplastic diseases. Clin Chim Acta 2000, 291:171-187.
9. Herszényi L., Sipos F., Galamb O., Solymosi N., Hirtz I., Miheller P., et al. Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon. Pathol Oncol Res 2008, 14:31-37.
10. Ignar D.M., Andrews J.L., Whiterspoon S.M., Leray J.D., Clay W.C., Kilpatrick K., et al. Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist. Clin Exp Metastasis 1998, 16:9-20.
11. Inuzuka K., Ogata Y., Nagase H., Shirouzu K. Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma. J Surg Res 2000, 93:211-218.
12. Kopfstein L., Christofori G. Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci 2006, 63:449-468.
13. Langenskiöld M., Holmdahl L., Falk P., Ivarsson M.-L. Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer. Int J Colorectal Dis 2005, 20:245-252.
14. Li L., Akers K., Eisen A.Z., Seltzer J.L. Activation of gelatinase A(72-kDa type IV collagenase) induced by monensin in normal human fibroblasts. Exp Cell Res 1997, 232:322-330.
15. Lijnen H.R. Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Moscow) 2002, 67:92-98.
16. Marconi C.H., Bianchini F., Mannini A., Mugnai G., Guggieri S., Calorini L. Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells. Clin Exp Metastasis 2008, 25:225-231.
17. May A.E., Kanse S.M., Chavakis T., Preissner K.T. Molecular interactions between the urokinase receptor and integrins in the vasculature. Fibrynolysis Proteolysis 1998, 12:205-210.
18. Mc Donnell S., Chaudhry V., Mansilla-Soto J., Zeng Z.-S., Shu W.-P., Guillem J.G. Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo. Clin Exp Metastasis 1999, 17:341-349.
19. Ornstein D.L., MacNab J., Cohn K.H. Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer. Clin Exp Metastasis 1999, 17:205-212.
20. Paduch R., Kandefer-Szerszeń M. Vitamin D, tamoxifen and Β-estradiol modulate breast cancer growth and interleukin-6 and metalloproteinase-2 production in three-dimensional co-cultures of tumor cell spheroids with endothelium. Cell Biol Toxicol 2005, 21:247-256.
21. Piccolella M., Festuccia C., Millimaggi D., Locatelli A., Bologna M., Motta M., et al. suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion. Int J Oncol 2008, 32:185-191.
22. Sato T., Sakai T., Noguchi Y., Takita M., Hirakawa S., Ito A. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol Oncol 2004, 92:47-56.
23. Singer C.H.F., Kronsteiner N., Marton E., Kubista M., Cullen K.J., Hirtenlehner K., et al. MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Res Treat 2002, 72:69-77.
24. Spina C.S., Ton L., Yao M., Maehr H., Wolfe M.M., Uskokovic M., et al. Selective vitamin D receptor modulators and their effects on colorectal tumor growth. J Steroid Biochem Mol Biol 2007, 103:757-762.
25. Suzuki S., Hayashi Y., Wang Y., Nakamura T., Morita Y., Kawasaki K., et al. Urokinase type plasminogen activator receptor expression in colorectal neoplasms. Gut 1998, 43:798-805.
26. Taniguchi T., Lemoine N.R., Kakkar A.K. Urokinase receptor is a key player in tumor progression. Gut 1998, 43:739-740.
27. Zucker S., Vacirca J. Role of metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004, 23:101-117.